Physician profile
Anna C Fuller
NPI 1902340078
$1,030.25
in general payments reported to CMS, 2019-2025
10 companies · $74.40 in 2025
The $74.40 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.60 · 2022: $80.98 · 2023: $602 · 2024: $181 · 2025: $74.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747 · Education: $85.50 · Travel and Lodging: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.17 |
| Education | $85.50 |
| Travel and Lodging | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $382.55 | 2021-2023 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $250.02 | 2023-2024 | Selectsecure |
| Kestra Medical Technology Services, INC. | $143.00 | 2023-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $72.04 | 2023-2025 | Brilinta, Wainua, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.18 | 2023 | Lifevest |
| Cvrx, INC. | $45.01 | 2023 | Barostim Neo System |
| Cardiva Medical, INC. | $23.40 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Daiichi Sankyo INC. | $21.47 | 2023 | Injectafer |
| Merck Sharp & Dohme LLC | $20.35 | 2023 | Verquvo |
| Scpharmaceuticals INC. | $19.23 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.